20-36198013-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_012156.2(EPB41L1):c.1640C>G(p.Pro547Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00681 in 1,613,664 control chromosomes in the GnomAD database, including 62 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0052 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0070 ( 61 hom. )
Consequence
EPB41L1
NM_012156.2 missense
NM_012156.2 missense
Scores
1
9
8
Clinical Significance
Conservation
PhyloP100: 7.43
Publications
10 publications found
Genes affected
EPB41L1 (HGNC:3378): (erythrocyte membrane protein band 4.1 like 1) Erythrocyte membrane protein band 4.1 (EPB41) is a multifunctional protein that mediates interactions between the erythrocyte cytoskeleton and the overlying plasma membrane. The encoded protein binds and stabilizes D2 and D3 dopamine receptors at the neuronal plasma membrane. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2015]
EPB41L1 Gene-Disease associations (from GenCC):
- autosomal dominant non-syndromic intellectual disabilityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- complex neurodevelopmental disorderInheritance: AD Classification: LIMITED Submitted by: ClinGen
- intellectual disability, autosomal dominant 11Inheritance: AD Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.005582273).
BP6
Variant 20-36198013-C-G is Benign according to our data. Variant chr20-36198013-C-G is described in ClinVar as Benign. ClinVar VariationId is 128997.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAdExome4 allele frequency = 0.00698 (10202/1461444) while in subpopulation SAS AF = 0.017 (1464/86254). AF 95% confidence interval is 0.0162. There are 61 homozygotes in GnomAdExome4. There are 5308 alleles in the male GnomAdExome4 subpopulation. Median coverage is 38. This position passed quality control check.
BS2
High AC in GnomAd4 at 784 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| EPB41L1 | NM_012156.2 | c.1640C>G | p.Pro547Arg | missense_variant | Exon 14 of 22 | ENST00000338074.7 | NP_036288.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EPB41L1 | ENST00000338074.7 | c.1640C>G | p.Pro547Arg | missense_variant | Exon 14 of 22 | 1 | NM_012156.2 | ENSP00000337168.2 |
Frequencies
GnomAD3 genomes AF: 0.00515 AC: 784AN: 152102Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
784
AN:
152102
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00718 AC: 1785AN: 248490 AF XY: 0.00805 show subpopulations
GnomAD2 exomes
AF:
AC:
1785
AN:
248490
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00698 AC: 10202AN: 1461444Hom.: 61 Cov.: 38 AF XY: 0.00730 AC XY: 5308AN XY: 727020 show subpopulations
GnomAD4 exome
AF:
AC:
10202
AN:
1461444
Hom.:
Cov.:
38
AF XY:
AC XY:
5308
AN XY:
727020
show subpopulations
African (AFR)
AF:
AC:
38
AN:
33472
American (AMR)
AF:
AC:
114
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
AC:
139
AN:
26134
East Asian (EAS)
AF:
AC:
1
AN:
39698
South Asian (SAS)
AF:
AC:
1464
AN:
86254
European-Finnish (FIN)
AF:
AC:
314
AN:
53062
Middle Eastern (MID)
AF:
AC:
46
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
7710
AN:
1111970
Other (OTH)
AF:
AC:
376
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
640
1280
1920
2560
3200
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
288
576
864
1152
1440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00515 AC: 784AN: 152220Hom.: 1 Cov.: 32 AF XY: 0.00495 AC XY: 368AN XY: 74410 show subpopulations
GnomAD4 genome
AF:
AC:
784
AN:
152220
Hom.:
Cov.:
32
AF XY:
AC XY:
368
AN XY:
74410
show subpopulations
African (AFR)
AF:
AC:
58
AN:
41538
American (AMR)
AF:
AC:
77
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
AC:
18
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5164
South Asian (SAS)
AF:
AC:
79
AN:
4814
European-Finnish (FIN)
AF:
AC:
51
AN:
10602
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
484
AN:
68004
Other (OTH)
AF:
AC:
16
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
42
84
127
169
211
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
26
ALSPAC
AF:
AC:
17
ESP6500AA
AF:
AC:
9
ESP6500EA
AF:
AC:
71
ExAC
AF:
AC:
976
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
Nov 02, 2016
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Uncertain
.;.;.;.;.;T;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D;D;D;D;D;.;D
MetaRNN
Benign
T;T;T;T;T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Benign
.;.;.;.;.;N;.;.
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Benign
N;D;N;.;.;N;D;N
REVEL
Uncertain
Sift
Uncertain
D;D;D;.;.;D;D;D
Sift4G
Uncertain
D;D;D;D;T;D;D;T
Polyphen
B;D;B;.;P;D;.;.
Vest4
MVP
MPC
0.83
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.